Zymeworks Q3 EPS $2.28 Beats $2.18 Estimate, Sales $256.460M Beat $228.465M Estimate
Benzinga Newsdesk 3 hours ago
NewsEarningsEarnings Beats
Zymeworks (NASDAQ:ZYME) reported quarterly earnings of $2.28 per share which beat the analyst consensus estimate of $2.18 by 4.59 percent. This is a 976.92 percent increase over losses of $(0.26) per share from the same
Zymeworks (NASDAQ:ZYME) reported quarterly earnings of $2.28 per share which beat the analyst consensus estimate of $2.18 by 4.59 percent. This is a 976.92 percent increase over losses of $(0.26) per share from the same period last year. The company reported quarterly sales of $256.460 million which beat the analyst consensus estimate of $228.465 million by 12.25 percent. This is a 828.73 percent increase over sales of $27.614 million the same period last year.